Latest News

The private investment firms of the ultra wealthy raised their stock holdings in the second quarter, according to the latest CNBC Family Office Portfolio Tracker. Family offices also trimmed their exp

Spot gold and silver prices are little changed to weaker in early U.S. trading Thursday, as a firmer rates backdrop offset bargain hunting after Wednesday's post-PCE pullback.

Jinhui Shipping and Transportation Limited (JNSTF) Q2 2026 Earnings Call Transcript

Okta Inc (NASDAQ:OKTA) shares are set to open about 18% higher on Thursday after the identity management software company reported fiscal second-quarter results that beat Wall Street expectations for

Applied Nutrition PLC (LSE:APN) drew an increased target price from Deutsche Bank on Thursday, as the broker lifted its valuation following a strong pre-close trading update from the supplement maker.

I recommend BlackRock Science and Technology Term Trust with a Buy rating for diversified exposure to both public and private AI-driven technology equities. BSTZ's portfolio is concentrated in AI grow

Teradyne is well-positioned to benefit from rising AI-driven test complexity across compute, memory, and photonics, supporting a BUY rating. TER's diversified test platforms and early qualification in

Cognizant CEO honored for helping redefine enterprise AI transformation through workforce reinvention and next-generation operating models TEANECK, N.J., Aug. 27, 2026 /PRNewswire/ -- Cognizant (Nasda

Kansas City Fed President Jeffrey Schmid said Thursday that inflation has been "stubborn" and "sticky" though he did not commit to supporting an interest rate hike. However, he said he doesn't see the

San Francisco, California--(Newsfile Corp. - August 27, 2026) - Hagens Berman Sobol Shapiro LLP alerts investors in PROCEPT BioRobotics Corporation (NASDAQ: PRCT) that a securities class action has be

San Francisco, California--(Newsfile Corp. - August 27, 2026) - National investor rights law firm Hagens Berman highlights developments surrounding Capricor Therapeutics, Inc. (NASDAQ: CAPR). Followin

San Francisco, California--(Newsfile Corp. - August 27, 2026) - Hagens Berman Sobol Shapiro LLP alerts investors in Regeneron Pharmaceuticals (NASDAQ: REGN) that a securities class action lawsuit has

Hagens Berman Urges Investors with Significant Losses to Contact the Firm KEY DATES AND FIGURES Class Period: Dec. 10, 2025 - May 27, 2026 Lead Plaintiff Deadline: Sept. 4, 2026 Case Page: www.hbsslaw

San Francisco, California--(Newsfile Corp. - August 27, 2026) - Hagens Berman, a national law firm noted for its preeminent work in securities class action litigation, notifies investors in HDFC Bank

This article was written by Doug Nathman, with research by his team at Trefis.

Accelleron Industries AG (ACLLY) Q2 2026 Earnings Call Transcript

Zymeworks Inc. is transitioning from a development-stage biotech to a royalty-driven, revenue-generating platform following zanidatamab's FDA approval. Zanidatamab's first-line HER2+ gastroesophageal

Okta remains a Buy, supported by steady revenue growth, expanding enterprise accounts, and improving margins. OKTA's FY27 guidance targets 10-11% revenue growth, 26% non-GAAP operating margin, and 28-

VanEck Morningstar Wide Moat ETF delivered strong recent outperformance, gaining 10.23% versus peers since my last review, driven by deeply discounted valuations and overweighted software stocks. MOAT

AT&T is upgraded to Strong Buy, reflecting improved FCF guidance, pricing power, and earnings acceleration. T now guides FCF to $18B for 2026, with coverage and dividend growth prospects improving an